Anti-DEFM/ PDF functional antibody

Anti-DEFM/ PDF functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to PDF/PDF products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T89515-Ab-1/ GM-Tg-hg-T89515-Ab-2Anti-Human PDF monoclonal antibodyHuman
GM-Tg-rg-T89515-Ab-1/ GM-Tg-rg-T89515-Ab-2Anti-Rat PDF monoclonal antibodyRat
GM-Tg-mg-T89515-Ab-1/ GM-Tg-mg-T89515-Ab-2Anti-Mouse PDF monoclonal antibodyMouse
GM-Tg-cynog-T89515-Ab-1/ GM-Tg-cynog-T89515-Ab-2Anti-Cynomolgus/ Rhesus macaque PDF monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T89515-Ab-1/ GM-Tg-felg-T89515-Ab-2Anti-Feline PDF monoclonal antibodyFeline
GM-Tg-cang-T89515-Ab-1/ GM-Tg-cang-T89515-Ab-2Anti-Canine PDF monoclonal antibodyCanine
GM-Tg-bovg-T89515-Ab-1/ GM-Tg-bovg-T89515-Ab-2Anti-Bovine PDF monoclonal antibodyBovine
GM-Tg-equg-T89515-Ab-1/ GM-Tg-equg-T89515-Ab-2Anti-Equine PDF monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T89515-Ab-1/ GM-Tg-hg-T89515-Ab-2; GM-Tg-rg-T89515-Ab-1/ GM-Tg-rg-T89515-Ab-2;
GM-Tg-mg-T89515-Ab-1/ GM-Tg-mg-T89515-Ab-2; GM-Tg-cynog-T89515-Ab-1/ GM-Tg-cynog-T89515-Ab-2;
GM-Tg-felg-T89515-Ab-1/ GM-Tg-felg-T89515-Ab-2; GM-Tg-cang-T89515-Ab-1/ GM-Tg-cang-T89515-Ab-2;
GM-Tg-bovg-T89515-Ab-1/ GM-Tg-bovg-T89515-Ab-2; GM-Tg-equg-T89515-Ab-1/ GM-Tg-equg-T89515-Ab-2
Products NameAnti-PDF monoclonal antibody
Formatmab
Target NamePDF
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PDF benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T89515-Ag-1Recombinant multi-species DEFM/ PDF protein


    Target information

    Target IDGM-T89515
    Target NamePDF
    Gene ID64146,68023,690214,100427223,788473,100146718
    Gene Symbol and Synonyms2610019N19Rik,PDF
    Uniprot AccessionQ9HBH1
    Uniprot Entry NameDEFM_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000258429
    Target ClassificationN/A

    The target: PDF, gene name: PDF, also named as . Protein synthesis proceeds after formylation of methionine by methionyl-tRNA formyl transferase (FMT) and transfer of the charged initiator f-met tRNA to the ribosome. In eubacteria and eukaryotic organelles the product of this gene, peptide deformylase (PDF), removes the formyl group from the initiating methionine of nascent peptides. In eubacteria, deformylation of nascent peptides is required for subsequent cleavage of initiating methionines by methionine aminopeptidase. The discovery that a natural inhibitor of PDF, actinonin, acts as an antimicrobial agent in some bacteria has spurred intensive research into the design of bacterial-specific PDF inhibitors. In human cells, only mitochondrial proteins have N-formylation of initiating methionines. Protein inhibitors of PDF or siRNAs of PDF block the growth of cancer cell lines but have no effect on normal cell growth. In humans, PDF function may therefore be restricted to rapidly growing cells. [provided by RefSeq, Nov 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.